Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT Glioblastoma

NCT07347210 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Primary Glioblastoma

Interventions

DRUG: UCPVax
DRUG: Pembrolizumab
DRUG: Temozolomide

Sponsor

Centre Hospitalier Universitaire de Besancon

Collaborators

[object Object]